Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Paoletti

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Biochemistry|February 12, 1991
Bis(pyrrolecarboxamide) linked to intercalating chromophore oxazolopyridocarbazole (OPC): selective binding to DNA and polynucleotidesF Subra, S Carteau, J Pager, et al.
The Journal of Clinical Investigation|November 1, 1990
Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B StreptococcusM R Wessels, L C Paoletti, D L Kasper, et al.
Infection and Immunity|November 1, 1993
Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccineM R Wessels, L C Paoletti, A K Rodewald, et al.
British Journal of Cancer|March 14, 2007
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II studyB Neri, P Pantaleo, E Giommoni, et al.
Applied and Environmental Microbiology|March 14, 2007
VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinantsF Biavasco, G Foglia, C Paoletti, et al.
Gene|December 10, 1988
Alpha-anomeric DNA: beta-RNA hybrids as new synthetic inhibitors of Escherichia coli RNase H, Drosophila embryo RNase H and M-MLV reverse transcriptaseE Bloch, M Lavignon, J R Bertrand, et al.
Transplantation Proceedings|September 27, 2005
The treatment of fistulae and ureteral stenosis after kidney transplantationV Li Marzi, M T Filocamo, E Dattolo, et al.
The Journal of Infectious Diseases|December 8, 1998
Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and IbC J Baker, L C Paoletti, M R Wessels, et al.
Cancer Research|December 1, 1987
Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HClC Auclair, A Pierre, E Voisin, et al.
The Journal of Clinical Investigation|November 15, 1996
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccineD L Kasper, L C Paoletti, M R Wessels, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Biochemistry|February 12, 1991
Bis(pyrrolecarboxamide) linked to intercalating chromophore oxazolopyridocarbazole (OPC): selective binding to DNA and polynucleotidesF Subra, S Carteau, J Pager, et al.
The Journal of Clinical Investigation|November 1, 1990
Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B StreptococcusM R Wessels, L C Paoletti, D L Kasper, et al.
Infection and Immunity|November 1, 1993
Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccineM R Wessels, L C Paoletti, A K Rodewald, et al.
British Journal of Cancer|March 14, 2007
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II studyB Neri, P Pantaleo, E Giommoni, et al.
Applied and Environmental Microbiology|March 14, 2007
VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinantsF Biavasco, G Foglia, C Paoletti, et al.
Gene|December 10, 1988
Alpha-anomeric DNA: beta-RNA hybrids as new synthetic inhibitors of Escherichia coli RNase H, Drosophila embryo RNase H and M-MLV reverse transcriptaseE Bloch, M Lavignon, J R Bertrand, et al.
Transplantation Proceedings|September 27, 2005
The treatment of fistulae and ureteral stenosis after kidney transplantationV Li Marzi, M T Filocamo, E Dattolo, et al.
The Journal of Infectious Diseases|December 8, 1998
Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and IbC J Baker, L C Paoletti, M R Wessels, et al.
Cancer Research|December 1, 1987
Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HClC Auclair, A Pierre, E Voisin, et al.
The Journal of Clinical Investigation|November 15, 1996
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccineD L Kasper, L C Paoletti, M R Wessels, et al.
Pageof 20